Leading Growth Driver in the Cat Vaccine Market in 2025: Rising Zoonotic Diseases Fuel The Growth Of The Cat Vaccine Market Driver's Influence

What Are the Market Size and Growth Forecast for the Cat Vaccine Market?
There has been notable growth in the cat vaccine market size in the past few years. The market is projected to expand from $1.15 billion in 2024 to $1.26 billion in 2025, with a compound annual growth rate (CAGR) of 9.3%. Factors contributing to the growth during the past period include the surge of new diseases affecting cats, an increase in the prevalence of animal diseases, growth in livestock populations, a rise in companion animal populations, and an uptick in the incidence of zoonotic diseases.

Anticipated for a substantial surge in the impending years, the cat vaccine market is forecasted to reach a valuation of $1.78 billion by 2029, growing at a compound annual growth rate (CAGR) of 9.0%. This predicted growth over the forecast span can be credited to several factors such as an increase in pet adoption, a rise in disposable income, a surge in demand for veterinary services, initiatives from government and veterinary bodies, as well as heightened awareness of animal wellness among the populace. Preeminent trends during the forecast timeline include the creation of cutting-edge cat vaccines, the introduction of innovative and effective solutions, emerging vaccine technologies, the evolution of combination vaccines, and the enhancement of personalized vaccinations.

What Is Contributing to the Growth of the Cat Vaccine Market?
The escalating incidences of zoonotic diseases, that is, diseases that transition from animals to humans, are anticipated to boost the cat vaccine market's development. These diseases are caused by bacteria, viruses, fungi, or parasites and can be transmitted directly or via vectors or infected environments. They include Lyme disease, rabies, toxoplasmosis, salmonellosis, brucellosis, and more. They are becoming prevalent due to changes in the climate, antibiotic resistance, and both legal and illegal wildlife trade. Cat vaccines help in managing these diseases by decreasing the chances of them passing from cats to humans. Diseases such as cat scratch fever and toxoplasmosis can be vaccinated against in cats, which is a measure that not only controls the diseases' effect on human health but also buttresses public health initiatives and guarantees a healthier environment for pets and pet owners. For instance, a Government of the United Kingdom report from February 2024 states that England had 335 confirmed Lyme disease cases in the last quarter of 2023, exceeding the 273 cases from the same timeframe in 2022. Hence, the expanding presence of zoonotic diseases fuels the expansion of the cat vaccine market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20526&type=smp

Which Key Market Leaders Are Driving Cat Vaccine Industry Growth?
Major companies operating in the cat vaccine market are Merck & Co. Inc., Boehringer Ingelheim International GmbH, Zoetis Inc., MSD Animal Health, Elanco Animal Health Incorporated, Intas Pharmaceuticals Ltd., Ceva Santé Animale, Virbac, Neogen Corporation, Indian Immunologicals Ltd., Jinyu Bio-technology Co. Ltd., Ourofino Animal Health SA, Biogénesis Bagó SA, Valley Vet Supply, HIPRA Corporation, Bioveta AS, China Animal Husbandry Group, Veterinary Pharmaceutical Solutions, Torigen Pharmaceuticals Inc., KM Vet Pharm Sdn Bhd.

Which Key Market Leaders Are Driving Industry Growth?
Leading corporations in the cat vaccine industry are channelling their efforts into the creation of unique products like the NOBIVAC NXT vaccines. This innovative product leverages the latest RNA-particle technology to boost immune responses, increase the effectiveness of the vaccine, and offer specific protection against feline diseases. RNA-particle technology is a groundbreaking method that employs RNA molecules packed within nanoparticles, which deliver genetic directives to cells and stimulate them to yield certain proteins inducing a targeted immune reaction. For example, MSD Animal Health Inc., a US pharmaceutical firm, introduced the NOBIVAC NXT Rabies portfolio, including NOBIVAC NXT Feline-3 Rabies and NOBIVAC NXT Canine-3 Rabies in June 2024. This all-inclusive vaccination solution was designed to confer robust protection against rabies in dogs and cats. Remarkably, the NOBIVAC NXT vaccines are free of adjuvants and preservatives, amplifying their safety while ensuring their effectiveness. These vaccines activate both humoral (antibody-mediated) and cell-mediated immune responses, facilitating comprehensive protection against the rabies virus.

What Are the Main Segments in the Cat Vaccine Market?
The cat vaccine market covered in this report is segmented -

1) By Vaccine Type: Modified Or Attenuated Live, Inactivated, Other Vaccine Types
2) By Disease Type: Feline Leukemia, Feline Panleukopenia, Feline Respiratory Diseases, Feline Rabies, Other Diseases
3) By Technology: Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, Deoxyribonucleic Acid (DNA) Vaccines, Recombinant Vaccines
4) By Route Of Administration: Injectables, Intranasal, Oral
5) By Distribution Channel: Veterinary Clinics, Pet Stores, Online Retailers

Subsegments:
1) By Modified or Attenuated Live: Feline Viral Rhinotracheitis (FVR) Vaccine, Feline Calicivirus (FCV) Vaccine, Feline Panleukopenia (FPV) Vaccine
2) By Inactivated: Inactivated Feline Leukemia Virus (FeLV) Vaccine, Inactivated Feline Infectious Peritonitis (FIP) Vaccine
3) By Other Vaccine Types: Recombinant Vaccines, DNA Vaccines, Subunit Vaccines, Combination Vaccines

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/cat-vaccine-global-market-report

Which Geographic Area Leads the Cat Vaccine Market?
North America was the largest region in the cat vaccine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cat vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Cat Vaccine Global Market Report?

- Market Size Analysis: Analyze the cat vaccine Market Size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the cat vaccine market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall cat vaccine market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the cat vaccine market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20526

Learn More About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.